HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Gnant Selected Research

Breast Neoplasms (Breast Cancer)

8/2022Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry.
1/2022Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18.
10/2021Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.
1/2021A clinical validation study of MammaPrint in hormone receptor-positive breast cancer from the Austrian Breast and Colorectal Cancer Study Group 8 (ABCSG-8) biomarker cohort.
1/2021PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial.
1/2021ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6.
10/2019Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019.
8/2019Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.
1/2019Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial.
1/2019De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Gnant Research Topics

Disease

51Breast Neoplasms (Breast Cancer)
08/2022 - 01/2000
21Neoplasms (Cancer)
08/2022 - 01/2000
11Neoplasm Metastasis (Metastasis)
01/2019 - 03/2008
5Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 02/2015
2Noninfiltrating Intraductal Carcinoma (DCIS)
01/2017 - 04/2004
2Brain Neoplasms (Brain Tumor)
01/2012 - 01/2012
2Colonic Neoplasms (Colon Cancer)
10/2007 - 05/2005
2Hepatocellular Carcinoma (Hepatoma)
12/2001 - 01/2001
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Osteoporosis
01/2022
1Diarrhea
01/2019
1Fistula
01/2018
1Pancreatic Fistula (Pancreatic Fistulas)
01/2018
1Residual Neoplasm
01/2017
1Primary Ovarian Insufficiency
08/2015
1Hyperglycemia
04/2014
1Pneumonia (Pneumonitis)
04/2014
1Stomatitis
04/2014
1Pathologic Complete Response
02/2014
1Obesity
09/2013
1Male Breast Neoplasms (Male Breast Cancer)
06/2013
1Overweight
04/2013
1Premature Menopause
10/2012
1Triple Negative Breast Neoplasms
01/2012
1Lymphatic Metastasis
05/2010
1Lung Neoplasms (Lung Cancer)
11/2009
1Multiple Myeloma
11/2009
1Hypercalcemia (Milk Alkali Syndrome)
11/2009
1Calcinosis
03/2009
1Metabolic Bone Diseases (Osteopenia)
03/2008
1Bone Diseases (Bone Disease)
03/2008

Drug/Important Bio-Agent (IBA)

15Hormones (Hormone)IBA
08/2022 - 03/2003
7Estrogen ReceptorsIBA
01/2021 - 06/2001
5Trastuzumab (Herceptin)FDA Link
01/2019 - 11/2008
5Zoledronic Acid (Zometa)FDA Link
03/2016 - 03/2008
5Aromatase InhibitorsIBA
12/2014 - 12/2011
4Proteins (Proteins, Gene)FDA Link
08/2022 - 06/2001
4Biological ProductsIBA
10/2021 - 02/2007
4TamoxifenFDA LinkGeneric
01/2021 - 04/2013
4Diphosphonates (Bisphosphonates)IBA
01/2017 - 03/2008
3ParaffinIBA
08/2022 - 08/2008
3Anastrozole (Arimidex)FDA LinkGeneric
01/2021 - 08/2013
3Progesterone Receptors (Progesterone Receptor)IBA
01/2021 - 04/2003
3Clodronic Acid (Clodronate)IBA
03/2016 - 03/2008
3AnthracyclinesIBA
08/2015 - 04/2003
3Docetaxel (Taxotere)FDA Link
02/2014 - 11/2008
3Fluorouracil (Carac)FDA LinkGeneric
10/2007 - 04/2003
2Plasminogen Activator Inhibitor 1IBA
08/2022 - 08/2019
2human ERBB2 proteinIBA
01/2021 - 05/2010
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2019
2Epidermal Growth Factor (EGF)IBA
01/2019 - 12/2014
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
08/2015 - 06/2013
2Paclitaxel (Taxol)FDA LinkGeneric
08/2015 - 01/2000
2exemestane (Aromasin)FDA Link
12/2014 - 04/2014
2EverolimusFDA Link
12/2014 - 04/2014
2Epirubicin (Ellence)FDA LinkGeneric
02/2014 - 10/2010
2Estrogens (Estrogen)FDA Link
11/2012 - 10/2012
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
08/2022
1Plasminogen InactivatorsIBA
08/2022
1DenosumabFDA Link
01/2022
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022
1CholesterolIBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Formaldehyde (Formol)FDA Link
01/2021
1ERRalpha Estrogen-Related ReceptorIBA
01/2019
1neratinibIBA
01/2019
1AmylasesFDA Link
01/2018
1Fibrin Tissue Adhesive (Fibrin Sealant)IBA
01/2018
1Goserelin (Zoladex)FDA Link
02/2015
1TOR Serine-Threonine KinasesIBA
04/2014
1Pharmaceutical PreparationsIBA
04/2014
1Capecitabine (Xeloda)FDA Link
02/2014
1Estradiol (Delestrogen)FDA LinkGeneric
09/2013
1Aminoglutethimide (Cytadren)FDA Link
04/2013
1Dihydrotachysterol (AT 10)IBA
03/2013
1Phenobarbital (Luminal)FDA Link
01/2012
1Lapatinib (GW572016)FDA Link
01/2012
1ProteomeIBA
10/2010
1Complement System Proteins (Complement)IBA
10/2010
1Thrombospondin 1IBA
08/2010
1Vascular Endothelial Growth Factor CIBA
05/2010
1Taxoids (Taxanes)IBA
11/2008
1taxaneIBA
11/2008
1Leucovorin (Folinic Acid)FDA Link
10/2007
1Levamisole (Decaris)FDA Link
05/2005
1Interferon-alpha (Interferon Alfa)IBA
05/2005
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2003
1Vinblastine (Vinblastine Sulfate)FDA Link
04/2003
1Methotrexate (Mexate)FDA LinkGeneric
04/2003

Therapy/Procedure

26Therapeutics
10/2021 - 05/2005
8Drug Therapy (Chemotherapy)
01/2017 - 01/2000
6Neoadjuvant Therapy
10/2021 - 01/2000
6Adjuvant Chemotherapy
01/2019 - 04/2003
2Aftercare (After-Treatment)
12/2014 - 04/2014
1Length of Stay
01/2018
1Pancreaticoduodenectomy
01/2018
1Segmental Mastectomy (Lumpectomy)
02/2012
1Oral Administration
03/2008
1CMF regimen
04/2003